The first year of the Trump Administration has brought significant changes to the Department of Justice (DOJ) and the Department of Health and Human Services (HHS), the two federal agencies with primary responsibility for investigating and enforcing alleged violations of federal law arising from the life sciences industry. This webinar will provide an insider’s account of how such investigations are handled within DOJ and HHS — from initiating an investigation to the filing of a complaint or indictment through the resolution of the matter — and how the policies, priorities, and procedures for investigating and enforcing violations of the False Claims Act, the Food, Drug, and Cosmetic Act, and other relevant statutes have shifted over the Administration’s first year.